Ontology highlight
ABSTRACT: Background
Fibroblast growth factor 21 (FGF21) is deemed to play an important role in kidney outcomes, while the association between FGF21 and various kidney diseases remains largely unclear and inconsistent. Therefore, we conducted this meta-analysis to find out the role of FGF21 in various renal diseases.Methods
The outcome indicator of our study was assessed by the pooled standard mean difference (SMD) with 95% confidence intervals (CIs) which were calculated by random-effect model analysis. The risk of bias was assessed by Non-Randomized Studies of Interventions (ROBINS-I) tool. Funnel plot combined with Egger's and Begg's tests was performed to estimate the publication bias that existed in the study.Results
A total of 28 eligible studies with 19348 participants
SUBMITTER: Yong G
PROVIDER: S-EPMC10071947 | biostudies-literature | 2023 Dec
REPOSITORIES: biostudies-literature